Literature DB >> 29774370

IL-33/s-ST2 ratio, systemic symptoms, and basophil activation in Pru p 3-sensitized allergic patients.

Carina G Uasuf1, Caterina Di Sano1, Sebastiano Gangemi2, Giuseppe Albeggiani1, Diego Cigna1, Paola Dino1, Ignazio Brusca3, Mark Gjomarkaj1, Elisabetta Pace4.   

Abstract

BACKGROUND: Although IL-33/ST2 axis is involved in the development of allergic diseases, its contribution in food allergy is still unknown.
METHODS: In this study, we assessed the serum levels of IL-33 and its s-ST2 receptor in 53 control patients (without allergic diseases), 47 peach (Pru p 3)-sensitized allergic patients (SAP), and in 68 non-Pru p 3-SAP. Basophil activation test (BAT) was used to assess the basophil activation due to allergen exposure before and after the addition of s-ST2 to the blood samples from 5 Pru p 3-SAP.
RESULTS: IL-33 levels in Pru p 3-SAP were higher than in non-Pru p 3-SAP and in normal controls. Lower s-ST2 levels were found in Pru p 3-SAP than in non-Pru p 3-SAP. IL-33/s-ST2 ratio was higher in Pru p 3-SAP than in both non-Pru p 3-SAP and controls. Higher IL-33/s-ST2 ratio was observed in Pru p 3-SAP with severe than in those with mild systemic symptoms. BAT analysis in Pru p 3-SAP showed a decrease in basophil activation due to Pru p 3 exposure after the addition of s-ST2 to the blood samples.
CONCLUSIONS: An imbalance in the baseline levels of IL-33/ST2 pathway is present in Pru p 3-SAP. The measurement of this pathway might be helpful to detect patients at a higher risk of developing severe systemic symptoms.

Entities:  

Keywords:  Anaphylaxis; Basophil activation test; Food allergy; IL-33 receptor; Non-specific lipid-transfer protein; Panallergens; Peach allergy; sIgE to Pru p 3; sST2

Mesh:

Substances:

Year:  2018        PMID: 29774370     DOI: 10.1007/s00011-018-1157-4

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  32 in total

1.  Increased IL-33 expression by epithelial cells in bronchial asthma.

Authors:  David Préfontaine; Jessica Nadigel; Fazila Chouiali; Séverine Audusseau; Abdelhabib Semlali; Jamila Chakir; James G Martin; Qutayba Hamid
Journal:  J Allergy Clin Immunol       Date:  2010-02-11       Impact factor: 10.793

Review 2.  The role of lipid transfer proteins in allergic diseases.

Authors:  Matthias Egger; Michael Hauser; Adriano Mari; Fatima Ferreira; Gabriele Gadermaier
Journal:  Curr Allergy Asthma Rep       Date:  2010-09       Impact factor: 4.806

3.  The role of IL-33 and its receptor ST2 in human nasal epithelium with allergic rhinitis.

Authors:  R Kamekura; T Kojima; K Takano; M Go; N Sawada; T Himi
Journal:  Clin Exp Allergy       Date:  2012-02       Impact factor: 5.018

Review 4.  Type I IL-1 receptor (IL-1RI) as potential new therapeutic target for bronchial asthma.

Authors:  Jyh-Hong Lee; Li-Chieh Wang; Hsin-Hui Yu; Yu-Tsan Lin; Yao-Hsu Yang; Bor-Luen Chiang
Journal:  Mediators Inflamm       Date:  2010-07-05       Impact factor: 4.711

5.  Activated mast cells synthesize and release soluble ST2-a decoy receptor for IL-33.

Authors:  Geethani Bandara; Michael A Beaven; Ana Olivera; Alasdair M Gilfillan; Dean D Metcalfe
Journal:  Eur J Immunol       Date:  2015-09-09       Impact factor: 5.532

6.  Causes of food-induced anaphylaxis in Italian adults: a multi-centre study.

Authors:  R Asero; L Antonicelli; A Arena; L Bommarito; B Caruso; G Colombo; M Crivellaro; M De Carli; E Della Torre; F Della Torre; E Heffler; F Lodi Rizzini; R Longo; G Manzotti; M Marcotulli; A Melchiorre; P Minale; P Morandi; B Moreni; A Moschella; F Murzilli; F Nebiolo; M Poppa; S Randazzo; G Rossi; G E Senna
Journal:  Int Arch Allergy Immunol       Date:  2009-06-04       Impact factor: 2.749

Review 7.  Lipid transfer protein allergy: primary food allergy or pollen/food syndrome in some cases.

Authors:  Laurian Zuidmeer; Ronald van Ree
Journal:  Curr Opin Allergy Clin Immunol       Date:  2007-06

Review 8.  Interleukin (IL)-33: new therapeutic target for atopic diseases.

Authors:  Takeshi Nabe
Journal:  J Pharmacol Sci       Date:  2014-09-10       Impact factor: 3.337

Review 9.  Minimal persistent inflammation, an emerging concept in the nature and treatment of allergic rhinitis: the possible role of leukotrienes.

Authors:  William W Storms
Journal:  Ann Allergy Asthma Immunol       Date:  2003-08       Impact factor: 6.347

10.  Vitamin D enhances production of soluble ST2, inhibiting the action of IL-33.

Authors:  Paul E Pfeffer; Yin-Huai Chen; Grzegorz Woszczek; Nick C Matthews; Elfy Chevretton; Atul Gupta; Sejal Saglani; Andrew Bush; Chris Corrigan; David J Cousins; Catherine M Hawrylowicz
Journal:  J Allergy Clin Immunol       Date:  2014-11-12       Impact factor: 10.793

View more
  1 in total

Review 1.  Mast Cells and Vitamin D Status: A Clinical and Biological Link in the Onset of Allergy and Bone Diseases.

Authors:  Giuseppe Murdaca; Alessandro Allegra; Alessandro Tonacci; Caterina Musolino; Luisa Ricciardi; Sebastiano Gangemi
Journal:  Biomedicines       Date:  2022-08-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.